Skip to main content
OpenTrials
Completed

NCT Number: NCT04013360

Acute Effect of Positive Expiratory Pressure Versus Breath Stacking Technique After Cardiac Surgery

This study evaluates the efficacy and safety of a single session of positive expiratory pressure and of breath stacking technique in patients after cardiac surgery. The same patients will receive the two interventions, with an interval of 24 hours, and the acute effect of each will be verifed.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Complication, Postoperative Cardiac Complication Pathologic Processes Pathological Conditions, Signs and Symptoms Postoperative Complications

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Federal University of Santa Maria

Santa Maria, Rio Grande do Sul, 97105-900, Brazil

About this study

Physiotherapy uses techniques and equipment that reduce postoperative pulmonary complications. The technique called breath stacking consists of an instrumental feature composed of a unidirectional valve coupled to a face mask to promote the accumulation of successive inspiratory volumes. The technique is used to prevent atelectasis and improve gas exchange. Another therapy is called expiratory positive airway pressure (EPAP) that uses positive end expiratory pressure (PEEP) in spontaneously breathing patients, keeping the airway open during expiration. The EPAP system consists of a face mask, a one-way valve and the expiratory resistor, which is responsible for resistance to expiratory flow, which will determine the level of PEEP.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patients with indication for coronary artery bypass grafting and valve replacement, with surgical procedure for median sternotomy.

Exclusion criteria

  • incapacity to understand the Informed Consent Form.
  • cognitive dysfunction that prevents the performance of evaluations or interventions,
  • intolerance to the use of EPAP or BS mask
  • with chronic obstructive pulmonary disease (COPD)
  • cerebrovascular disease
  • chronic-degenerative musculoskeletal disease
  • chronic infectious disease
  • in treatment with steroids, hormones or cancer chemotherapy
  • hemodynamic complications (arrhythmia, myocardial infarction during the operation, with blood loss ≥ 20% of the total blood volume, defined by Mannuci, et al., 2007)
  • mean arterial pressure <70 mmHg and reduced cardiac output, requiring the use of intra aortic balloon or vasoactive drugs
  • tracheal intubation for more than 12 hours after admission to the ICU or reintubated
  • individuals unable to maintain airway permeability.

Treatment and study plan

Breath Stacking

Other

The patients will perform the maneuver through successive inspiratory efforts for 20 s. Subsequently, the expiratory branch will be unobstructed to allow expiration. This maneuver will be repeated 5 times in each series, with intervals of 30 seconds between them. The technique will be performed with the trunk inclined 30º in relation to the horizontal plane, in 3 series, with interval of 2 min completing 15 min of therapy.

Expiratory Positive Airway Pressure

Other

Patients will perform exhalation of air through a facial mask containing an extrinsic positive expiratory pressure valve with a defined load of 10 cmH2O for 5 min. During the application of the technique the patients will have a trunk inclined 30º and will be stimulated to breathe normally, without effort or deep and fast breaths.

Primary outcomes

  1. Tidal volume

    Time frame: 12 to 24 hours after removal of drains and 24 hours after primary intervention

    It will be evaluated preoperatively and also before and after 10 minutes of each intervention, in the postoperative period. This measurement will be obtained through the the division of the minute volume by the respiratory rate.

  2. Forced vital capacity (FVC)

    Time frame: 12 to 24 hours after removal of drains and 24 hours after primary intervention

    It will be evaluated preoperatively and also before and after 10 minutes of each intervention, in the postoperative period, as recommended by the American Thoracic Society and European Respiratory Society (2006) and based on reproducibility and acceptability criteria, three maneuvers will be performed (variability <5%) and considered the best curve for the study.

Secondary outcomes

  1. Forced expiratory volume in the first second (FEV1)

    Time frame: 12 to 24 hours after removal of drains and 24 hours after primary intervention

    It will be evaluated preoperatively and also before and after 10 minutes of each intervention, in the postoperative period, as recommended by the American Thoracic Society and European Respiratory Society (2006) and based on reproducibility and acceptability criteria, three maneuvers will be performed (variability <5%) and considered the best curve for the study.

  2. Peak expiratory flow (PEF)

    Time frame: 12 to 24 hours after removal of drains and 24 hours after primary intervention

    It will be evaluated preoperatively and also before and after 10 minutes of each intervention, in the postoperative period, as recommended by the American Thoracic Society and European Respiratory Society (2006) and based on reproducibility and acceptability criteria, three maneuvers will be performed (variability <5%) and considered the best curve for the study.

  3. Forced expiratory flow between 25 and 75% of the curve of FVC (FEF25-75)

    Time frame: 12 to 24 hours after removal of drains and 24 hours after primary intervention

    It will be evaluated preoperatively and also before and after 10 minutes of each intervention, in the postoperative period, as recommended by the American Thoracic Society and European Respiratory Society (2006) and based on reproducibility and acceptability criteria, three maneuvers will be performed (variability <5%) and considered the best curve for the study.

  4. Minute volume

    Time frame: 12 to 24 hours after removal of drains and 24 hours after primary intervention

    It will be evaluated preoperatively and also before and after 10 minutes of each intervention. To obtain the Minute Volume (MV), the patient will be instructed to inhale and exhale slowly for one minute and the value of MV and respiratory rate (RR) will be recorded. The respiratory rate was measured by the movements of the rib cage during respiratory cycles performed in one minute. The MV will be obtained by a Wright ® ventilometer (British Oxigen Company, London, England).

  5. Respiratory rate

    Time frame: 12 to 24 hours after removal of drains and 24 hours after primary intervention

    They will be assessed at baseline, immediately after and 10 minutes after each intervention. The respiratory rate was measured by the movements of the rib cage during respiratory cycles performed in one minute.

  6. Heart rate

    Time frame: 12 to 24 hours after removal of drains and 24 hours after primary intervention

    They will be assessed at baseline, immediately after and 10 minutes after each intervention, through multi-parameter monitor.

  7. Peripheral Oxygen Saturation (SpO2)

    Time frame: 12 to 24 hours after removal of drains and 24 hours after primary intervention

    They will be assessed at baseline, immediately after and 10 minutes after each intervention through the G-Tech® portable pulse oximeter.

  8. Blood pressure

    Time frame: 12 to 24 hours after removal of drains and 24 hours after primary intervention

    They will be assessed at baseline, immediately after and 10 minutes after each intervention. The blood pressure will be obtained through multi-parameter monitor.

  9. Heart work measurement

    Time frame: 12 to 24 hours after removal of drains and 24 hours after primary intervention

    They will be assessed at baseline, immediately after and 10 minutes after each intervention through the calculation of the double product (multiplication of systolic blood pressure by heart rate).

  10. Thoracoabdominal mobility

    Time frame: 12 to 24 hours after removal of drains and 24 hours after primary intervention

    Will be evaluated by thoracic and abdominal cirtometry

  11. Painful perception in the surgical incision

    Time frame: 12 to 24 hours after removal of drains and 24 hours after primary intervention

    Will be assessed at baseline, immediately after and 10 minutes after each intervention through a Visual Analog Scale, a one-dimensional instrument for evaluation of pain intensity, with a range of 1 to 10.

  12. Degree of dyspnea

    Time frame: 12 to 24 hours after removal of drains and 24 hours after primary intervention

    Will be assessed at baseline, immediately after and 10 minutes after each intervention, through the Modified Borg Scale, a vertical scale quantified from 0 to 10. Zero represents no symptoms and 10 represents maximum symptoms.

  13. Signs of respiratory discomfort (dizziness, tachypnea, sweating, use accessory musculature)

    Time frame: 12 to 24 hours after removal of drains and 24 hours after primary intervention

    They will be assessed at baseline, immediately after and 10 minutes after each intervention, through clinical inspection.

Sponsors and collaborators

Lead sponsor

Universidade Federal de Santa Maria

Other

Registry information

Official study title

Acute Effect of Positive Expiratory Pressure Versus Breath Stacking Technique After Cardiac Surgery: a Randomized Crossover Trial

Important dates

Study start
2019
Primary completion
2019
Study completion
2020
First posted
Jul 9, 2019
Registry last updated
Apr 9, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.